Keller Eric L.
Reporting owner on Forms 3, 4 and 5, CIK 2156365.
Keller Eric L. reported on 1 issuer in 4 filings, the latest a Form 4 filed 2026-10-22.
Issuers
| Issuer | Roles in the latest filing | Filings | Last filed |
|---|---|---|---|
| Retension Pharmaceuticals, Inc. CIK 2002988 | director, officer (CHIEF EXECUTIVE OFFICER) | 3 | 2026-10-22 |
Transactions and holdings
Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.
| Security | Date | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| Retension Pharmaceuticals, … Stock Option (right to buy), derivative | 2026-10-22 | A granted | +40,884 | $0 | 40,884 | Form 4 |
| Retension Pharmaceuticals, … Common Stock | 2026-10-13 | P bought | +20,800 | $12 | 423,377 | Form 4 |
| Retension Pharmaceuticals, … Common Stock | 2026-10-13 | C converted | +9,662 | 433,039 | Form 4 | |
| Retension Pharmaceuticals, … Common Stock | 2026-10-13 | C converted | +31,368 | 464,407 | Form 4 | |
| Retension Pharmaceuticals, … Stock Option (right to buy), derivative | 2026-10-13 | A granted | +255,174 | $0 | 255,174 | Form 4 |
| Retension Pharmaceuticals, … Series A Convertible Preferred Stock, derivative | 2026-10-13 | C converted | -9,662 | 0 | Form 4 | |
| Retension Pharmaceuticals, … Series B Convertible Preferred Stock, derivative | 2026-10-13 | C converted | -31,368 | 0 | Form 4 | |
| Retension Pharmaceuticals, … Common Stock, holding | 402,577 | Form 3 | ||||
| Retension Pharmaceuticals, … Stock Option (right to buy), derivative, holding | Form 3 | |||||
| Retension Pharmaceuticals, … Stock Option (right to buy), derivative, holding | Form 3 | |||||
| Retension Pharmaceuticals, … Stock Option (right to buy), derivative, holding | Form 3 | |||||
| Retension Pharmaceuticals, … Series A Convertible Preferred Stock, derivative, holding | Form 3 | |||||
| Retension Pharmaceuticals, … Series B Convertible Preferred Stock, derivative, holding | Form 3 |
Filings
The person's Forms 3, 4 and 5, and any 13D or 13G naming it.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| Form 4 0001213900-26-111795 | Retension Pharmaceuticals, Inc. | 2026-10-22 | ||
| 13D 0001213900-26-109425 | RTSN | 2026-10-14 | ||
| Form 4 0001213900-26-109160 | Retension Pharmaceuticals, Inc. | 2026-10-13 | ||
| Form 3 0001213900-26-108135 | Retension Pharmaceuticals, Inc. | 2026-10-08 |